quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:30:00·38d
PRRelease
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office

PHIO· Phio Pharmaceuticals Corp.
Health Care
Original source

Companies

  • PHIO
    Phio Pharmaceuticals Corp.
    Health Care

Recent analyst ratings

  • Jun 5UpdateH.C. Wainwright$14.00

Related

  • PR1d
    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
  • PR11d
    Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
  • PR15d
    Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
  • SEC15d
    Phio Pharmaceuticals Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
  • SEC15d
    SEC Form 424B5 filed by Phio Pharmaceuticals Corp.
  • SEC25d
    Phio Pharmaceuticals Corp. filed SEC Form 8-K: Other Events
  • PR25d
    Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
  • PR32d
    Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022